Maplight Therapeutics - 普信集团投资管理(T. Rowe Price Investment Management)旗下账户表示有意以IPO价格购买最多4000万美元的股份。
Maplight Therapeutics - 普信集团投资管理(T. Rowe Price Investment Management)旗下账户表示有意以IPO价格购买最多4000万美元的股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.